05/05/2026
On Friday, the Fifth Circuit Court of Appeals issued a ruling ordering the FDA to temporarily impose medically unnecessary in-person dispensing requirements on mifepristone. The ruling effectively blocked access to abortion medication by mail for patients across the country.
On Monday, the US Supreme Court temporarily blocked the ruling until May 11, allowing telehealth and mailing of mifepristone to resume, as it has since the FDA permanently removed the in-person dispensing requirement in 2023.
What does this mean for Ohioans?
First, our most important message was to let patients know that Ohio abortion clinics are open for service. When headlines talk about banning abortion, many people can get confused and believe that their ability to access care is blocked.
Second, Ohioans who want to obtain abortion medication by mail are impacted by orders on the FDA from the Fifth Circuit, even though that court's jurisdiction is in Louisiana.
Ohioans can still get mifepristone by mail through May 11, but a new court fight leaves the future of abortion pill access uncertain.